Clinical trialPhase 3Completed
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Randomized Phase III Study of Gemcitabine Versus TS-1 Versus Gemcitabine Plus TS-1 in Unresectable Advanced Pancreatic Cancer (With Local Progression or Metastasis)
- Outcome
- Finished, no results posted
- Phase
- Phase 3
- Status
- Completed
- Study type
- Interventional
- Start
- July 2007
- Expected end
- June 2012
- Enrollment
- 834 participants
- Sites
- 12
- Primary outcomes
- Over all survival(OS)
- Sponsor
- Industry
- Results posted
- No
- Last update
- 2 November 2012
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 2
- Builds on itUpdated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer. DOI 10.1007/s00432-017-2349-y↗
- Builds on itRandomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced a… DOI 10.1200/jco.2012.43.3680↗